Harrow Health is trading now at $39.23, down 5.08%, with no new company-specific announcement or analyst action identified for August 26, 2026.
- Latest company disclosures were the August 20 IHEEZO data announcement and August 10 second-quarter results.
- The Nasdaq Composite is down 0.29%, but that move is insufficient to establish a clear market-wide cause; the specific catalyst remains unclear.